6851 - 6875 of 9117 Results
Title
Year
-
OPENTitle: Metabolomics and the search for biomarkers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 12Start Page: 1620End Page: 1621Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25644Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4050667Citation Count: 11
-
RESTRICTEDTitle: Disease‐related and genetic correlates of psychotic symptoms in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 12Start Page: 2190End Page: 2195Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.23806Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4216677Citation Count: 68
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia2012OPENTitle: β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementiaJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 296End Page: 301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25213Best OA location URL: https://hdl.handle.net/2027.42/97160Citation Count: 96
-
OPENTitle: Measuring mild cognitive impairment in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 5Start Page: 626End Page: 633Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25426Best OA location URL: http://doi.org/10.1002/mds.25426Citation Count: 145
-
OPENTitle: Heterogeneity in primary dystonia: Lessons from THAP1, GNAL, and TOR1A in Amish‐MennonitesJournal Name: Movement DisordersPublisher: WileyVol: 29Issue #: 6Start Page: 812End Page: 818Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25818Best OA location URL: http://doi.org/10.1002/mds.25818Citation Count: 38
-
RESTRICTEDTitle: Reliability of a new scale for essential tremorJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 12Start Page: 1567End Page: 1569Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25162Best OA location URL: http://doi.org/10.1002/mds.25162Citation Count: 241
-
OPENTitle: Parkinson disease phenotype in Ashkenazi jews with and without LRRK2 G2019S mutationsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 1966End Page: 1971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25647Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3859844Citation Count: 143
-
OPENTitle: The association between Mediterranean diet adherence and Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 6Start Page: 771End Page: 774Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.24918Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3349773Citation Count: 226
-
OPENTitle: Caffeine consumption and risk of dyskinesia in CALM‐PDJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 380End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25319Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3608707Citation Count: 58
-
OPENTitle: Patient‐control association study of the Leucine‐Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 14Start Page: 2039End Page: 2040Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25637Best OA location URL: http://doi.org/10.1002/mds.25637Citation Count: 9
-
RESTRICTEDTitle: Brain amyloid and cognition in Lewy body diseasesJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 8Start Page: 965End Page: 973Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25048Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3725259Citation Count: 169
-
OPENTitle: β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control StudyJournal Name: Clinical EpidemiologyPublisher: Informa UK LimitedVol: Volume 15Issue #:Start Page: 695End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/clep.s405325Best OA location URL: https://www.dovepress.com/getfile.php?fileID=90360Citation Count: 8
-
OPENTitle: Mechanisms of VPS35-mediated neurodegeneration in Parkinson's diseaseJournal Name: International Review of Movement DisordersPublisher: ElsevierVol:Issue #:Start Page: 221End Page: 244Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/bs.irmvd.2021.08.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9053314Citation Count: 23
-
OPENTitle: Home-Based Augmented Reality Gait-and-Balance Therapy in Parkinson Disease: An Examination of Exercise IntensityJournal Name: Archives of Physical Medicine and RehabilitationPublisher: Elsevier BVVol: 107Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.apmr.2025.12.008Best OA location URL: https://doi.org/10.1016/j.apmr.2025.12.008Citation Count: 1
-
OPENTitle: Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primatesJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 25Start Page: eadu6050End Page: eadu6050Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adu6050Best OA location URL: https://doi.org/10.1126/sciadv.adu6050Citation Count: 5
-
OPENTitle: Integrated proteogenetic analysis reveals the landscape of a mitochondrial-autophagosome synapse during PARK2-dependent mitophagyJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 5Issue #: 11Start Page: eaay4624End Page: eaay4624Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.aay4624Best OA location URL: https://advances.sciencemag.org/content/advances/5/11/eaay4624.full.pdfCitation Count: 77
- LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary Neurons2021OPENTitle: LRRK2 Kinase Activity Does Not Alter Cell-Autonomous Tau Pathology Development in Primary NeuronsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 3Start Page: 1187End Page: 1196Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212562Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212562?id=journal-of-parkinsons-disease%2Fjpd212562Citation Count: 8
-
OPENTitle: Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeysJournal Name: eBioMedicinePublisher: Elsevier BVVol: 59Issue #:Start Page: 102944End Page: 102944Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2020.102944Best OA location URL: http://www.thelancet.com/article/S2352396420303200/pdfCitation Count: 77
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2010RESTRICTEDTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Citation Count: 47
-
OPENTitle: LRRK2 and idiopathic Parkinson’s diseaseJournal Name: Trends in NeurosciencesPublisher: Elsevier BVVol: 45Issue #: 3Start Page: 224End Page: 236Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.tins.2021.12.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8854345Citation Count: 157
-
OPENTitle: MPP+‐dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neuronsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 169Issue #: 1Start Page: 130End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.12104Citation Count: 29
-
OPENTitle: Involvement of Perineuronal and Perisynaptic Extracellular Matrix in Alzheimer's Disease NeuropathologyJournal Name: Brain PathologyPublisher: WileyVol: 22Issue #: 4Start Page: 547End Page: 561Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2011.00557.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3639011Citation Count: 153
-
RESTRICTEDTitle: Age-related changes in glutathione and glutathione-related enzymes in rat brainJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1090Issue #: 1Start Page: 35End Page: 44Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2006.03.063Best OA location URL: http://doi.org/10.1016/j.brainres.2006.03.063Citation Count: 278
-
OPENTitle: CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1408Issue #:Start Page: 88End Page: 97Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2011.06.057Best OA location URL: http://doi.org/10.1016/j.brainres.2011.06.057Citation Count: 78
-
OPENTitle: Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological declineJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 139Issue #: 9Start Page: 2420End Page: 2430Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww180Best OA location URL: https://academic.oup.com/brain/article-pdf/139/9/2420/17944760/aww180.pdfCitation Count: 83